ArticleCurrent issues in molecular biology2021

TET2 Mutation and High miR-22 Expression as Biomarkers to Predict Clinical Outcome in Myelodysplastic Syndrome Patients Treated with Hypomethylating Therapy.

Jina Yun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.